{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:32:10Z","timestamp":1774657930863,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2016.00031","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T12:41:16Z","timestamp":1474375276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis"],"prefix":"10.3389","volume":"3","author":[{"given":"Pietro Enea","family":"Lazzerini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Leopoldo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Bertolozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Morozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sauro","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Simpatico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Selvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Romana","family":"Bacarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Acampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deana","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"El-Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Laghi-Pasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.115.009800","article-title":"Pathogenesis of the novel autoimmune-associated long QT syndrome","volume":"132","author":"Yue","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"B3","doi-asserted-by":"publisher","first-page":"e003419","DOI":"10.1161\/CIRCEP.115.003419","article-title":"Arrhythmogenicity of anti-Ro\/SSA antibodies in patients with torsades de pointes","volume":"9","author":"Lazzerini","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw208","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","author":"Lazzerini","year":"2016","journal-title":"Eur Heart J"},{"key":"B5","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"Chauhan","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ejim.2013.02.009","article-title":"Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis","volume":"24","author":"Lazzerini","year":"2013","journal-title":"Eur J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/rheumatology\/ket338","article-title":"Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden","volume":"53","author":"Panoulas","year":"2014","journal-title":"Rheumatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3109\/14397595.2013.854072","article-title":"Evaluation of Tp-e interval and Tp-e\/QT ratio in patients with ankylosing spondylitis","volume":"24","author":"Acar","year":"2014","journal-title":"Mod Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"901215","DOI":"10.1155\/2013\/901215","article-title":"Increased risk of atrial and ventricular arrhythmia in long-lasting psoriasis patients","volume":"2013","author":"Simsek","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"B10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.autrev.2014.05.007","article-title":"Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation","volume":"13","author":"Lazzerini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"H431","DOI":"10.1152\/ajpheart.00431.2002","article-title":"Calcium-dependent arrhythmias in transgenic mice with heart failure","volume":"284","author":"London","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"H2098","DOI":"10.1152\/ajpheart.00097.2005","article-title":"Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha","volume":"290","author":"Petkova-Kirova","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1253\/circj.70.605","article-title":"Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts","volume":"70","author":"Kawada","year":"2006","journal-title":"Circ J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIRCRESAHA.110.229112","article-title":"Nuclear factor kappaB downregulates the transient outward potassium current I(to,f) through control of KChIP2 expression","volume":"108","author":"Panama","year":"2011","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"H238","DOI":"10.1152\/ajpheart.01122.2006","article-title":"TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation","volume":"293","author":"Fern\u00e1ndez-Velasco","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13289","DOI":"10.1074\/jbc.C400025200","article-title":"Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator","volume":"279","author":"Wang","year":"2004","journal-title":"J Biol Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/cvr\/27.3.525","article-title":"Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells","volume":"27","author":"Li","year":"1993","journal-title":"Cardiovasc Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.yjmcc.2007.09.004","article-title":"SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes","volume":"43","author":"Hagiwara","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fcvm.2015.00026","article-title":"Long QT syndrome:an emerging role for inflammation and immunity","volume":"2","author":"Lazzerini","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden death in rheumatoid arthritis. A population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B21","first-page":"886","article-title":"Rheumatoid heart: report of a case with endomyocardial injury and severe arrhythmias","volume":"8","author":"Di Lorenzo","year":"1978","journal-title":"G Ital Cardiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.2169\/naika.80.1673","article-title":"A case of anti-RNP antibody positive malignant rheumatoid arthritis with pulmonary hypertension","volume":"80","author":"Tsuji","year":"1991","journal-title":"Nihon Naika Gakkai Zasshi"},{"key":"B23","first-page":"33","article-title":"Clarithromycin-induced prolonged QT syndrome","volume":"49","author":"Lai","year":"1996","journal-title":"Can J Hosp Pharm"},{"key":"B24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1086\/339075","article-title":"Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors","volume":"34","author":"Bertino","year":"2002","journal-title":"Clin Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1024\/1661-8157.98.24.1409","article-title":"Medication associated long QT syndrome","volume":"98","author":"Bruggisser","year":"2009","journal-title":"Praxis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.recesp.2011.05.015","article-title":"Extreme QT interval prolongation and helicoid ventricular tachycardia (torsade de pointes) in non-ST-elevation acute coronary syndrome","volume":"65","author":"Vilaseca-Corbera","year":"2012","journal-title":"Rev Esp Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2049936113497203","article-title":"Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports","volume":"1","author":"Vieweg","year":"2013","journal-title":"Ther Adv Infect Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.psym.2014.09.002","article-title":"Citalopram, QTc prolongation, and torsades de pointes","volume":"56","author":"Tampi","year":"2015","journal-title":"Psychosomatics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jaad.2015.06.023","article-title":"Increased risk of arrhythmia in patients with psoriatic disease: a nationwide population-based matched cohort study","volume":"73","author":"Chiu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3899\/jrheum.140861","article-title":"Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis","volume":"42","author":"Adlan","year":"2015","journal-title":"J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/acr.22455","article-title":"Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis:Tocilizumab reduces QTc interval by controlling systemic inflammation","volume":"67","author":"Lazzerini","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/art.39198","article-title":"Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the women\u2019s health initiative","volume":"67","author":"Mackey","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.pharmthera.2008.03.006","article-title":"The canine model with chronic, complete atrio-ventricular block","volume":"119","author":"Oros","year":"2008","journal-title":"Pharmacol Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.hrthm.2014.10.007","article-title":"Atherosclerosis exacerbates arrhythmia after myocardial infarction: role of myocardial inflammation","volume":"12","author":"De Jesus","year":"2015","journal-title":"Heart Rhythm"},{"issue":"45","key":"B36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.fjc.0000151930.12026.b7","article-title":"Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction","volume":"2005","author":"Yu","year":"2005","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"deposited":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T17:00:26Z","timestamp":1475600426000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fcvm.2016.00031\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3389\/fcvm.2016.00031","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]}}}